Over the past few years, the Middle East has taken significant strides in implementing traceability regulations, particularly in countries like the UAE, Bahrain, and Saudi Arabia. With governments prioritizing patient safety and counterfeit prevention, serialization and traceability requirements have become mandatory in the pharmaceutical and healthcare supply chain.
However, compliance has not been a straightforward journey. While traceability initiatives brought much-needed transparency, serialization operations introduced a new layer of operational and technical complexity that organizations are still grappling with.
Implementing serialization is not just about printing barcodes or generating unique identifiers. It’s about embedding a robust, tamper-proof digital trail into an already diverse and fragmented supply chain. For many companies operating across the Middle East, the real challenge has been adapting serialization and aggregation into their daily workflows without disrupting operations or eroding profit margins.
Here are a few key scenarios and pain points that have emerged:
This mix of preparedness across the ecosystem has created inconsistencies, making it difficult to maintain end-to-end visibility.
Serialization and aggregation introduced an entirely new set of operational hurdles:
These challenges make it clear that serialization is not a plug-and-play solution, it’s a dynamic operational model that requires alignment across the supply chain.
Ironically, companies that invested in serialization software often faced additional hurdles. Many legacy systems, built with the intention of simplifying workflows and increasing accuracy, ended up doing the opposite. Misconfigurations, lack of interoperability, and poor user interfaces made day-to-day operations more complex instead of more efficient.
A serialization system, to be effective, must be:
Any deviation—however small—can result in cascading issues downstream, affecting shipments, product availability, and compliance reporting.
While the region has made commendable progress, the journey is far from over. To move forward, stakeholders must focus on:
Serialization and traceability are not just regulatory checkboxes - they are the foundation for a safer, more transparent healthcare supply chain. The Middle East is well on its way, but continued collaboration, innovation, and adaptability will be essential in making these systems truly seamless.
The cost of oversight in serialization is high. But with the right focus and systems in place, the benefits in terms of compliance, safety, and trust far outweigh the challenges.
We provide serialization consulting, implementation & integration services to help our clients with managing the end-to-end serialization projects and preparing them for the existing and upcoming regulations across the globe.
We are well versed with the compliance regulations for various markets and can help you with implementing the Middle East pharmaceutical serialization requirements.
Our team of experts strategize and plan end-to-end solutions using a combination of years of knowledge in product serialization, pharmaceutical supply chains, life sciences and brand integrity.
This information is being provided ‘As Is’ with no claims of suitability for a particular purpose. It represents just one possible interpretation of information available in the public domain or through membership organizations, and that interpretation is subject to change. This information does not constitute legal advice. Users must refer to the source material for the complete requirements and form their own interpretation before making business decisions. Please use the references below to follow the updates at the source.